Targeting HERI/EGFR: A molecular approach to cancer therapy

被引：196

作者：

Arteaga, C

机构：

[1] Vanderbilt Univ, Sch Med,Div Oncol, Dept Med,Breast Canc Res Program, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Sch Med,Div Oncol, Dept Canc Biol,Breast Canc Res Program, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA

来源：

SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 03期

关键词：

D O I：

10.1016/S0093-7754(03)00185-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3 / 14

页数：12

共 97 条

[21]

CROMBET T, 2002, P AN M AM SOC CLIN, V21, pA14

[22] Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype [J].

Damstrup, L ;

Pedersen, MW ;

Bastholm, L ;

Elling, F ;

Poulsen, HS .

INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (01) :7-14

[23]

De Jong JS, 1998, J PATHOL, V184, P53, DOI 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO

[24]

2-7

[25] Immunohistochemical comparative analysis of transforming growth factor α, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates [J].

De Miguel, MP ;

Royuela, M ;

Bethencourt, FR ;

Ruiz, A ;

Fraile, B ;

Paniagua, R .

CYTOKINE, 1999, 11 (09) :722-727

[26]

DELARCO JE, 1980, J BIOL CHEM, V255, P3685

[27]

DEPALAZZO IEG, 1993, CANCER RES, V53, P3217

[28]

Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438

[29]

FINKLER N, 2001, P AN M AM SOC CLIN, V20, pA208

[30]

FUKOUKA M, 2002, P AN M AM SOC CLIN, V21, pA298

← 1 2 3 4 5 6 7 8 9 10 →